1. Introduction

De-Extinction Governance refers to the legal, ethical, scientific, environmental and institutional framework governing attempts to recreate extinct species or restore extinct biological characteristics through advanced biotechnology.

De-extinction involves scientific techniques such as:

Genome editing: Using technologies such as CRISPR-Cas9 to introduce genetic characteristics associated with extinct species.

Cloning: Attempting to reproduce an organism using preserved genetic material or cells.

Selective breeding: Reintroducing ancestral characteristics into living species through controlled breeding.

Synthetic biology: Constructing or modifying genetic material to produce organisms resembling extinct species.

Genetic reconstruction: Reconstructing parts of an extinct organism's genome using ancient DNA and computational techniques.

Examples include proposed attempts to recreate characteristics of the woolly mammoth, thylacine (Tasmanian tiger), passenger pigeon and other extinct organisms.

De-extinction is not simply a scientific exercise. It raises important legal questions:

Who owns the genetic material of extinct species?

Can an extinct organism receive legal protection?

Who is responsible if a recreated organism causes ecological damage?

Can biotechnology companies patent genetically reconstructed organisms?

Who authorises the release of recreated species into natural ecosystems?

What happens when de-extinction technology threatens existing biodiversity?

Consequently, de-extinction governance requires coordination between environmental law, biotechnology regulation, intellectual property law, animal welfare, biodiversity protection and international law.

2. Meaning and Scope of De-Extinction Governance

De-extinction governance establishes rules for the entire lifecycle of an attempted species restoration project.

Its scope includes:

A. Research governance: Regulation of ancient DNA collection, genetic sequencing, genome reconstruction and laboratory experiments.

B. Biosafety governance: Assessment of the risks associated with genetically modified or reconstructed organisms.

C. Environmental governance: Evaluation of ecological consequences before introducing reconstructed organisms into natural environments.

D. Intellectual property governance: Determination of patentability, ownership, licensing and commercialisation rights.

E. Animal welfare governance: Protection of surrogate animals, laboratory animals and newly created organisms.

F. Public accountability: Ensuring that researchers, biotechnology companies, universities and government authorities remain legally accountable.

G. International cooperation: Regulation of cross-border genetic resources, biodiversity conservation and the movement of reconstructed organisms.

3. Major Legal Issues in De-Extinction Governance

A. Ownership of Extinct Genetic Resources

One of the most complicated legal questions concerns ownership of genetic material extracted from extinct organisms.

Ancient DNA may be obtained from:

Museum specimens.

Preserved biological tissues.

Fossil remains.

Frozen animal remains.

Indigenous or community-controlled territories.

Public and private scientific collections.

The legal position may differ depending on the origin of the biological material, applicable property law, collection permits and biodiversity legislation.

For example, a biotechnology company cannot automatically assume that obtaining a genetic sequence gives it unrestricted ownership of the original biological resource.

The Nagoya Protocol on Access and Benefit-sharing is relevant where genetic resources fall within its scope. It establishes access and benefit-sharing obligations, including the role of prior informed consent and mutually agreed terms under applicable national law.

B. Patent Rights Over Reconstructed Organisms

De-extinction creates difficult patent questions.

A biotechnology company might seek patents over:

Reconstructed genetic sequences.

Genome-editing techniques.

Synthetic biological constructs.

Modified reproductive technologies.

Genetically engineered organisms.

However, patent protection depends on the relevant national patent legislation.

A naturally occurring genetic sequence is not automatically patentable merely because it has been discovered. An engineered invention may qualify if it satisfies applicable requirements of novelty, inventive step and industrial applicability.

In India, Section 3(j) of the Patents Act 1970 excludes plants and animals in whole or in part, other than microorganisms, including essentially biological processes for their production or propagation.

Therefore, the patentability of a de-extinction invention in India requires careful examination of the particular claim.

C. Environmental Release and Ecological Risk

Reconstructed organisms may create environmental consequences that were not present in the original ecosystem.

Potential risks include:

Competition with existing species.

Transmission of diseases.

Genetic contamination.

Disruption of food chains.

Changes in habitat structure.

Invasive-species behaviour.

Unpredictable evolutionary consequences.

A recreated organism may possess genetic similarities to an extinct species without reproducing its original ecological behaviour.

Therefore, environmental approval should not be based exclusively on genetic similarity.

D. Animal Welfare and Surrogate Mothers

Many proposed de-extinction techniques involve embryos, reproductive technologies and surrogate animals.

These procedures may create risks such as:

Failed pregnancies.

Developmental abnormalities.

Embryonic mortality.

Reproductive complications.

Unnecessary experimentation.

Long-term suffering of genetically modified animals.

Animal welfare legislation must therefore apply throughout research, reproduction, testing and post-birth monitoring.

E. Indigenous Rights and Traditional Knowledge

De-extinction projects may involve genetic resources obtained from territories associated with Indigenous communities.

Such projects can raise questions concerning:

Indigenous sovereignty.

Traditional ecological knowledge.

Cultural heritage.

Prior informed consent.

Benefit-sharing.

Community participation.

Scientific ownership should not automatically override legally recognised community rights or applicable access-and-benefit-sharing requirements.

4. Important International Legal Frameworks

A. Convention on Biological Diversity, 1992

The Convention on Biological Diversity (CBD) is important because it establishes obligations concerning biodiversity conservation, sustainable use and equitable benefit-sharing.

Its relevance to de-extinction includes:

Conservation of biological diversity.

Protection of ecosystems and genetic resources.

Regulation of access to genetic resources.

Fair sharing of benefits arising from genetic-resource utilisation.

Environmental assessment of activities that may significantly affect biodiversity.

Article 8 concerns in-situ conservation, while Article 14 addresses environmental impact assessment and minimisation of adverse effects.

A de-extinction project should therefore be evaluated according to its contribution to biodiversity conservation and its possible ecological consequences.

B. Cartagena Protocol on Biosafety, 2000

The Cartagena Protocol on Biosafety is particularly relevant where a recreated organism qualifies as a living modified organism resulting from modern biotechnology and falls within the Protocol's scope.

Its major principles include:

Advance informed agreement for certain transboundary movements.

Risk assessment before relevant transfers.

Risk management and precautionary measures.

Information exchange concerning living modified organisms.

Protection of biodiversity, taking into account risks to human health.

A genetically reconstructed animal intended for environmental release may require biosafety assessment depending on its characteristics and the applicable treaty definitions.

C. Nagoya Protocol, 2010

The Nagoya Protocol governs access to genetic resources and the fair and equitable sharing of benefits arising from their utilisation, within its scope.

It is relevant when de-extinction research uses genetic resources subject to applicable national access-and-benefit-sharing laws.

For example, if researchers obtain biological material from a country that regulates access to that resource, they may need to comply with prior informed consent, mutually agreed terms and benefit-sharing requirements.

D. CITES, 1973

The Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) regulates international trade in specimens of species listed in its Appendices.

De-extinction raises an important classification problem: whether a reconstructed organism belongs to an extinct species, represents a genetically modified living species, or constitutes a distinct biological entity.

Its legal classification may determine whether CITES controls apply to its international movement or trade.

E. International Union for Conservation of Nature (IUCN)

The International Union for Conservation of Nature (IUCN) provides scientific guidance concerning biodiversity conservation and species assessment.

Its conservation work is relevant to determining whether de-extinction projects genuinely support ecosystem restoration or divert resources from protecting currently endangered species.

The IUCN's 2019 report on synthetic biology and biodiversity conservation also identifies uncertainties concerning the legal status of de-extinct organisms.

5. De-Extinction Governance in India

India does not have a single comprehensive statute specifically dedicated to de-extinction. Instead, several existing legal frameworks may apply.

A. Biological Diversity Act, 2002

The Biological Diversity Act, 2002 provides the legal framework for conservation of biological diversity, sustainable use and fair and equitable sharing of benefits.

Its relevance includes:

Access to biological resources.

Regulation of specified activities involving foreign individuals and entities.

Benefit-sharing requirements.

Protection of associated traditional knowledge.

Regulatory oversight through biodiversity institutions.

The 2023 amendment must also be considered when determining the current regulatory position.

A de-extinction project involving Indian biological resources cannot assume that genetic research is exempt from biodiversity-related obligations merely because the organism being reconstructed is extinct.

B. Environment (Protection) Act, 1986

The Environment (Protection) Act, 1986 provides broad powers to the Central Government to protect and improve environmental quality.

It is relevant to:

Environmental risk assessment.

Restrictions on hazardous biological activities.

Regulatory conditions.

Prevention of environmental contamination.

Monitoring and enforcement.

C. Rules, 1989: Genetically Engineered Organisms

The Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms, Genetically Engineered Organisms or Cells, 1989, issued under the Environment (Protection) Act, are particularly relevant.

They establish regulatory oversight involving institutions such as:

Institutional Biosafety Committees (IBSCs).

Review Committee on Genetic Manipulation (RCGM).

Genetic Engineering Appraisal Committee (GEAC).

State Biotechnology Coordination Committees.

District Level Committees.

Where a de-extinction project involves genetically engineered organisms covered by these Rules, the relevant approvals and biosafety requirements must be followed.

D. Wildlife (Protection) Act, 1972

The Wild Life (Protection) Act, 1972 protects specified wildlife species and regulates activities involving wildlife.

Important questions include:

Whether a reconstructed animal falls within an existing protected species classification.

Whether its possession, transport or transfer requires permission.

Whether it can be released into a protected area.

Whether its introduction threatens native wildlife.

The Act's application will depend on the organism's legal classification and the particular activity.

E. Patents Act, 1970

Indian patent law raises significant questions concerning de-extinction inventions.

Relevant provisions include:

Section 2(1)(j): Invention.

Section 3(b): Inventions contrary to public order or morality or causing serious prejudice to life, health or the environment.

Section 3(c): Discovery of a living thing or non-living substance occurring in nature.

Section 3(j): Exclusion relating to plants, animals and essentially biological processes.

Section 10: Specification requirements.

A company may be able to seek protection for a qualifying technical invention, but it cannot automatically patent an extinct species merely by reconstructing its DNA.

6. Important Case Laws and Their Application to De-Extinction Governance

Important distinction: There is no established body of reported court judgments directly deciding whether de-extinction itself is lawful. The following decisions provide analogous principles that courts and regulators may apply.

Case 1: Gene Campaign v. Union of India (2024)

Citation: 2024 INSC 545, Supreme Court of India.

This case concerned the regulatory approval for the environmental release of genetically modified mustard, particularly DMH-11.

The Supreme Court examined:

The legality of regulatory approval.

Environmental risk assessment.

Application of the precautionary principle.

Public and institutional participation.

Judicial review of decisions concerning genetically modified organisms.

The judgment produced separate opinions on important aspects of the approval process. The Court directed the Union Government to formulate a national policy on genetically modified crops through consultation with relevant stakeholders.

Relevance to de-extinction:

A reconstructed animal should not be released into the environment simply because a scientific institution considers its genetic reconstruction successful.

Regulators should examine ecological risks, scientific evidence, public participation and the adequacy of environmental safeguards.

The judgment also establishes that regulatory decisions concerning genetically modified organisms are subject to judicial review.

VoxJuris+2

Case 2: Vellore Citizens' Welfare Forum v. Union of India (1996)

Citation: (1996) 5 SCC 647.

The Supreme Court recognised the precautionary principle and the polluter-pays principle as essential components of Indian environmental law.

The Court emphasised that environmental protection cannot always wait until scientific certainty is available.

Relevance to de-extinction:

Suppose a biotechnology company recreates an extinct predator and proposes its introduction into a forest.

If there is uncertainty about its effect on existing wildlife, regulators should adopt preventive safeguards rather than wait for ecological damage.

The precautionary principle supports:

Controlled experimental environments.

Independent ecological assessments.

Limited release conditions.

Long-term environmental monitoring.

Suspension of activities where serious risks emerge.

Case 3: Indian Council for Enviro-Legal Action v. Union of India (1996)

Citation: (1996) 3 SCC 212.

The Supreme Court applied the polluter-pays principle in dealing with environmental damage caused by industrial activities.

The case supports the proposition that entities responsible for environmental harm may be required to bear the costs of remediation.

Relevance to de-extinction:

If a recreated organism causes biodiversity damage, the responsible research institution or company may face environmental liability depending on the applicable statutory provisions and established legal principles.

Potential consequences include:

Environmental compensation.

Restoration expenses.

Regulatory penalties.

Civil liability.

Remedial directions.

Case 4: T.N. Godavarman Thirumulpad v. Union of India (1997)

Citation: (1997) 2 SCC 267.

This landmark environmental litigation established an expansive approach to forest protection and the interpretation of forest-related legal obligations.

The case demonstrates the importance of preserving ecological systems rather than treating environmental protection as limited to individual species.

Relevance to de-extinction:

The reintroduction of an extinct organism cannot be considered independently of the forest ecosystem in which it will live.

A de-extinction project should examine:

Habitat suitability.

Forest carrying capacity.

Effects on native species.

Biodiversity conservation.

Ecological restoration requirements.

Case 5: Animal Welfare Board of India v. A. Nagaraja (2014)

Citation: (2014) 7 SCC 547.

The Supreme Court discussed animal welfare, dignity, freedom from unnecessary suffering and the statutory obligations under the Prevention of Cruelty to Animals Act, 1960.

Relevance to de-extinction:

De-extinction research may involve surrogate animals, embryo implantation, repeated reproductive experimentation and genetically modified offspring.

Scientific advancement cannot by itself justify unnecessary animal suffering.

Regulatory authorities should consider:

Humane reproductive procedures.

Veterinary supervision.

Ethical review.

Minimisation of failed experiments.

Welfare standards for recreated animals.

Case 6: Monsanto Canada Inc. v. Schmeiser (2004)

Citation: 2004 SCC 34, Supreme Court of Canada.

This case concerned patented genetically modified canola and the question of patent infringement arising from the presence and use of patented genetic material.

The Supreme Court of Canada considered the scope of patent rights over genetically modified technology.

Relevance to de-extinction:

A biotechnology company may develop proprietary genetic constructs or specialised genome-editing techniques used to recreate extinct characteristics.

The case illustrates how patent rights may become relevant when patented genetic technology is used in biological organisms.

However, it does not establish that a company owns an entire species merely because it holds patent rights over a particular genetic technology.

Case 7: African Centre for Biodiversity NPC v. Minister of Agriculture, Forestry and Fisheries (2024)

Citation: [2024] ZASCA 143, Supreme Court of Appeal of South Africa.

The case concerned regulatory approval involving genetically modified organisms.

The court set aside the approval because the decision-makers had failed to properly address whether the relevant environmental assessment requirements had been satisfied.

Relevance to de-extinction:

A regulator cannot rely exclusively on a technical approval process if other environmental assessment requirements are applicable.

A proposed de-extinction release may require multiple permissions, including biodiversity, biosafety and environmental approvals.

SAFLII

7. De-Extinction Governance in Australia

Australia is particularly important because it has distinctive biodiversity, endangered-species protection requirements and a history of species extinction, including the thylacine.

The following legislation is relevant.

A. Gene Technology Act 2000 (Cth)

The Act regulates dealings involving genetically modified organisms.

Its objectives include protecting human health and environmental safety through identification and management of risks associated with gene technology.

A de-extinction project involving a genetically modified organism may require regulatory authorisation before laboratory dealings, transportation, breeding or environmental release, depending on the applicable regulatory category.

The Office of the Gene Technology Regulator (OGTR) administers the regulatory framework.

Federal Register of Legislation+2

B. Environment Protection and Biodiversity Conservation Act 1999 (Cth)

The Environment Protection and Biodiversity Conservation Act 1999 may become relevant where a proposed project is likely to have a significant impact on a matter protected by the Act.

Relevant matters may include:

Threatened species and ecological communities.

World Heritage properties.

National heritage places.

Ramsar wetlands.

Commonwealth marine areas.

A de-extinction project involving environmental release must be examined to determine whether the proposed activity triggers Commonwealth environmental assessment and approval requirements.

C. Biosecurity Act 2015 (Cth)

The Biosecurity Act 2015 is relevant to biological risks associated with the importation and movement of organisms and biological material.

It may be important where reconstructed organisms, embryos, genetic material or biological samples cross Australian borders.

D. National Gene Technology Scheme

Australia's national regulatory framework requires authorisation for regulated dealings involving GMOs.

For an intentional environmental release, the Gene Technology Regulator prepares a Risk Assessment and Risk Management Plan (RARMP), with consultation requirements applying under the legislation.

This provides a useful regulatory model for de-extinction projects involving genetically modified organisms.

DAFF+1

8. Important Doctrines Governing De-Extinction

The following legal doctrines provide the theoretical foundation for de-extinction governance.

9. Major Regulatory Challenges

A. Legal Identity of Recreated Species

A major difficulty is determining whether a reconstructed organism legally qualifies as the extinct species or constitutes a new genetically modified organism.

For example, an animal containing selected woolly mammoth genetic characteristics introduced into an elephant genome may not necessarily be legally classified as an actual woolly mammoth.

This creates questions concerning:

Species classification.

Wildlife protection.

Conservation status.

International trade restrictions.

Ownership and registration.

B. Ecological Unpredictability

Genetic reconstruction cannot guarantee that an organism will behave like its extinct predecessor.

A reconstructed predator may have different hunting behaviour, reproductive patterns and environmental requirements.

Consequently, regulators should assess the whole organism and its ecological interactions rather than relying exclusively on genetic resemblance.

C. Commercialisation of De-Extinction

Private biotechnology companies may seek commercial opportunities through:

Genetic engineering patents.

Research licensing.

Reproductive technology.

Wildlife tourism.

Commercial breeding.

Genetic-resource exploitation.

Commercial incentives may conflict with biodiversity conservation if companies prioritise profitable species over ecologically important but commercially unattractive conservation projects.

D. Liability for Ecological Damage

Suppose a company releases genetically reconstructed birds into a protected ecosystem. These birds spread beyond the designated location and threaten native species.

Potential legal claims may involve:

Negligence.

Statutory environmental violations.

Breach of licence conditions.

Biodiversity damage.

Failure to comply with biosafety requirements.

Compensation and restoration obligations.

A proper governance system should identify the responsible parties before any release occurs.

E. Long-Term Monitoring

De-extinction governance should not end when an organism is successfully created.

Regulators should require monitoring of:

Genetic stability.

Reproductive behaviour.

Disease transmission.

Population growth.

Ecosystem interactions.

Habitat changes.

Animal welfare.

Monitoring obligations may need to continue across multiple generations.

10. Proposed Model for De-Extinction Governance

An effective legal framework should contain the following regulatory stages.

De-extinction regulatory lifecycle

Stage 1: Scientific research approval

Verification of genetic resources, research ethics and laboratory permissions.

Stage 2: Genetic and biosafety assessment

Evaluation of genetic modifications, biological stability and potential hazards.

Stage 3: Animal welfare assessment

Protection of surrogate animals, embryos and recreated organisms.

Stage 4: Environmental impact assessment

Evaluation of habitat suitability and ecological consequences.

Stage 5: Controlled release authorisation

Permission for limited experimental introduction, where legally appropriate.

Stage 6: Post-release monitoring

Long-term observation, reporting and corrective measures.

Stage 7: Liability and enforcement

Compensation, restoration, licence suspension and penalties where applicable.

A specialised de-extinction regulatory authority or coordinated inter-agency mechanism could oversee these stages.

It should include expertise from environmental science, biotechnology, veterinary medicine, biodiversity law, intellectual property and Indigenous community representatives.

11. Recommendations for Legal Reform

Several reforms could improve de-extinction governance.

1. Special legislative recognition: Governments should clarify the legal status of reconstructed organisms under wildlife and environmental legislation.

2. Mandatory ecological assessment: Environmental release should require a scientifically independent assessment of ecological risks.

3. Genetic-resource transparency: Research institutions should disclose the origin of biological material and demonstrate compliance with applicable access-and-benefit-sharing requirements.

4. Strict animal welfare standards: Reproductive experiments should undergo independent ethical assessment.

5. Patent limitations: Intellectual property rights should not be interpreted as unrestricted ownership of biological species or ecosystems.

6. International cooperation: Countries should coordinate cross-border movements, biosafety assessments and conservation monitoring.

7. Financial liability mechanisms: Developers should maintain adequate financial resources for monitoring, containment and ecological restoration.

8. Public participation: Indigenous communities, conservation organisations and affected local populations should have meaningful opportunities to participate in regulatory decisions.

12. Conclusion

De-extinction governance represents an emerging area of environmental and biotechnology law. It creates a legal intersection between genetic engineering, biodiversity conservation, intellectual property, animal welfare and environmental accountability.

The central challenge is not simply whether science can recreate an extinct organism, but whether society can legally and responsibly manage the consequences of bringing that organism back.

The decisions in Gene Campaign v. Union of India, Vellore Citizens' Welfare Forum v. Union of India, Indian Council for Enviro-Legal Action v. Union of India and Animal Welfare Board of India v. A. Nagaraja provide important legal principles for environmental precaution, regulatory accountability and animal protection.

Ultimately, de-extinction should be governed through a precautionary, transparent and scientifically accountable framework. Scientific innovation must remain compatible with biodiversity conservation, ecological stability and the welfare of living organisms.

13. Important Research References

For further academic and legal research, the following materials are particularly useful:

Alejandro E. Camacho, Going the Way of the Dodo: De-Extinction, Dualisms, and Reframing Conservation, 92 Washington University Law Review 849 (2015).

repository.library.washu.edu+1

Jessica Allen et al., De-Extinction, Regulation and Nature Conservation, Journal of Environmental Law, Volume 32 (2020).

Oxford Academic

IUCN, Genetic Frontiers for Conservation: An Assessment of Synthetic Biology and Biodiversity Conservation (2019).

IUCN Portals

Convention on Biological Diversity, 1992.

Cartagena Protocol on Biosafety, 2000.

Nagoya Protocol, 2010.

India's Biological Diversity Act, 2002.

Australia's Gene Technology Act 2000.

Central research proposition: De-extinction governance should recognise that recreating a biological organism does not automatically recreate its historical ecological identity, legal classification or conservation status. Regulatory approval must therefore address both the organism and the ecosystem into which it may be introduced.